| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |